Fitscript Offering GlucoseZone, Digital Exercise Treatment for Diabetics, for Free During COVID-19 Emergency

Share Article

Digital therapy product will help diabetics safely maintain critical fitness routines during pandemic

News Image

Fitscript LLC, a Connecticut venture-backed company helping people living with diabetes meet exercise requirements, today announced that the company is offering its digital therapeutic product, GlucoseZone, for free to any person living with diabetes during the COVID-19 emergency. GlucoseZone is the first patented and clinically validated digital therapy proven to use exercise to help people with diabetes maintain healthy weight and lower their A1c levels.

Access to safe and effective exercise is especially critical for people with diabetes during the pandemic, as people with diabetes are at higher risk from coronavirus than the general population. GlucoseZone makes it possible for them to safely and effectively exercise at home.

“GlucoseZone was created for people living with diabetes as a way to ensure they can get the safe and effective exercise they need wherever they are located,” said Charlie O’Connell, founder of GlucoseZone and patient entrepreneur. “For this reason, we are providing GlucoseZone for free to people living with diabetes who can’t get access to gyms and fitness centers during this COVID-19 emergency. Diabetes doesn’t stop for coronavirus, and people with diabetes need to maintain their fitness and be even more vigilant during this time.”

The GlucoseZone program is the first digital exercise solution that offers guidance, support and coaching based on the user’s individual requirements, including their real-time glucose levels and other biometric data captured from wearable devices such as glucose meters, insulin pumps and heart rate monitors. GlucoseZone enables people living with diabetes to incorporate exercise wherever they are and at whatever stage of their disease, and represents an important step in making affordable, real-time exercise support accessible using digital technology.

Fitscript is a Connecticut Innovations portfolio company that provides GlucoseZone to major health plans, providers and payers in the state, including the State of Connecticut’s Health Enhancement Program (HEP), the City of New Haven, Yale New Haven Health System, Griffin Health, ConnectiCare and others.

Diabetes and prediabetes impact the lives and health of more than 114 million Americans. GlucoseZone’s content has been accessed by millions of users around the world.

About GlucoseZone by Fitscript LLC:
Created in 2012, Fitscript LLC was founded to help people living with diabetes meet the exercise requirement for safely and effectively reducing and controlling their diabetes. Fitscript’s patented, proprietary GlucoseZone program, now with more than 1 million users, is the first-ever digital exercise solution for people with diabetes that helps improve their A1c levels and achieve weight loss based on real-time glucose levels. The GlucoseZone app contains live and on-demand exercise solutions, interactive workouts, diabetes discussions and much more. The app is available on iOS and Android. To learn more about GlucoseZone, please visit http://www.glucosezone.com. Connect with GlucoseZone’s social media channels: http://www.youtube.com/GlucoseZone and http://www.facebook.com/glucosezone.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Matt Walton
Visit website